- Investing Ideas
- /
- Global High Insider Buying
Global High Insider Buying
Results
2615
0 new
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,615 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$153.12 | 0.8% | -3.0% | US$368.7b | US$168.64 | PE26.2x | E8.4% | 3.2% | Pharmaceuticals & Biotech | ||
IBM | US$252.34 | -3.2% | 35.6% | US$233.3b | US$250.87 | PE38.8x | E12.5% | 2.6% | Software | ||
AZN | UK£116.00 | 2.9% | 22.1% | UK£179.9b | UK£140.10 | PE31.7x | E16.7% | 2.2% | Pharmaceuticals & Biotech | ||
HSBA | UK£8.54 | 3.9% | 40.4% | UK£150.1b | UK£8.75 | PB1x | E-0.6% | 5.8% | Banks | ||
CBA | AU$162.83 | 3.0% | 40.7% | AU$272.0b | AU$101.65 | PB3.7x | E4.4% | 2.9% | Banks | ||
LOW | US$251.94 | -1.8% | 9.6% | US$142.3b | US$282.24 | PE20.8x | E5.7% | 1.8% | Retail | ||
BHP | AU$40.09 | 2.2% | -13.0% | AU$205.3b | AU$44.62 | PE16.1x | E6.4% | 5.8% | Materials | ||
COP | US$98.36 | -0.1% | -11.5% | US$125.5b | US$131.80 | PE13.6x | E1.8% | 3.8% | Energy | ||
TD | CA$82.81 | 0.4% | 3.7% | CA$144.9b | CA$86.80 | PB1.3x | E11.5% | 5.1% | Banks | ||
INVE A | SEK 310.20 | 1.2% | 24.9% | SEK 951.2b | SEK 331.50 | PE8.4x | E-48.3% | 1.7% | Diversified Financials | ||
BP. | UK£4.33 | 3.2% | -9.6% | UK£67.9b | UK£4.83 | PE31x | E23.6% | 5.7% | Energy | ||
TRI | CA$252.31 | 2.4% | 21.3% | CA$113.6b | CA$252.28 | PE36.3x | E-1.4% | 1.3% | Commercial Services | ||
ATCO A | SEK 183.65 | 0.4% | 7.2% | SEK 860.9b | SEK 188.14 | PE30x | E6.9% | 1.6% | Capital Goods | ||
NAB | AU$40.54 | 3.4% | 24.2% | AU$124.7b | AU$34.11 | PB2x | E2.0% | 4.2% | Banks | ||
ITW | US$255.56 | 0.05% | -0.3% | US$75.5b | US$262.36 | PE21.6x | E1.8% | 2.3% | Capital Goods | ||
WBC | AU$34.03 | 2.6% | 38.9% | AU$116.7b | AU$28.90 | PB1.6x | E-0.007% | 4.5% | Banks | ||
GSK | UK£14.43 | 3.2% | -11.3% | UK£58.9b | UK£18.04 | PE22.9x | E18.4% | 4.2% | Pharmaceuticals & Biotech | ||
1299 | HK$52.60 | -1.6% | -16.2% | HK$566.2b | HK$93.06 | PE14.9x | E13.7% | 3.1% | Insurance | ||
CRH | US$103.34 | 6.2% | 40.0% | US$69.9b | US$114.33 | PE20.2x | E9.6% | 1.4% | Materials | ||
SPG | US$179.94 | 3.8% | 23.5% | US$67.8b | US$190.00 | PB20.2x | E-0.5% | 4.7% | Real Estate | ||
CNR | CA$145.02 | 0.8% | -16.0% | CA$91.0b | CA$167.90 | PE20.5x | E8.2% | 2.3% | Transportation | ||
FDX | US$256.08 | 3.5% | 4.8% | US$61.7b | US$320.69 | PE15.9x | E12.8% | 2.2% | Transportation | ||
DGE | UK£22.22 | -6.0% | -23.1% | UK£49.4b | UK£26.22 | PE17x | E7.2% | 3.8% | Food, Beverage & Tobacco | ||
CPG | UK£27.59 | -1.6% | 25.4% | UK£46.8b | UK£27.45 | PE41.4x | E14.8% | 1.7% | Consumer Services |